Down‐regulation of Polo‐like kinase 4 (PLK4) induces G1 arrest via activation of the p38/p53/p21 signaling pathway in bladder cancer
Open Access
- 3 August 2021
- journal article
- research article
- Published by Wiley in FEBS Open Bio
- Vol. 11 (9) , 2631-2646
Abstract
Polo‐like kinase 4 (PLK4) has been reported to contribute to tumor growth, invasion, and metastasis. However, the role of PLK4 in human bladder cancer (BC) remains unclear. Here, we demonstrate the regulatory function of PLK4 in human BC progression. PLK4 is overexpressed in BC cell lines and tissues, and its overexpression correlated with poor prognosis. Our transcriptome analysis combined with subsequent functional assays indicated that PLK4 inhibition can suppress BC cell growth and induce cell cycle arrest at G1 phase via activation of the p38/p53/p21 pathway in vitro and in vivo. Overall, our data suggest that PLK4 is a critical regulator of BC cell proliferation, and thus, it may have potential as a novel molecular target for BC treatment.Keywords
Funding Information
- National Natural Science Foundation of China (81922046, 81903090, 81702519)
This publication has 42 references indexed in Scilit:
- Plk4 is required for cytokinesis and maintenance of chromosomal stabilityProceedings of the National Academy of Sciences, 2010
- Pathological roles of MAPK signaling pathways in human diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Oncogenic and Tumor Suppressive Roles of Polo-Like Kinases in Human Hepatocellular CarcinomaHepatology, 2009
- Lost in Transcription: p21 Repression, Mechanisms, and ConsequencesCancer Research, 2005
- Sak/Plk4 and mitotic fidelityOncogene, 2005
- The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppressionGene, 2004
- Proteomic Screen Finds pSer/pThr-Binding Domain Localizing Plk1 to Mitotic SubstratesScience, 2003
- The Sak polo-box comprises a structural domain sufficient for mitotic subcellular localizationNature Structural & Molecular Biology, 2002
- Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activityNature Genetics, 2002
- MAP kinase pathwaysProgress in Biophysics and Molecular Biology, 1999